ENTRY       D07283                      Drug
NAME        Esketamine (USAN/INN)
FORMULA     C13H16ClNO
EXACT_MASS  237.092
MOL_WEIGHT  237.7252
CLASS       Neuropsychiatric agent
             DG01498  NMDA receptor antagonist
            Metabolizing enzyme substrate
             DG02919  CYP2B6 substrate
             DG01642  CYP2C9 substrate
             DG01639  CYP2C19 substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
             DG02924  UGT substrate
REMARK      ATC code: N01AX14 N06AX27
            Chemical structure group: DG01829
            Product (DG01829): D10627<US>
EFFICACY    Antidepressant, NMDA receptor antagonist
COMMENT     Treatment of depression
TARGET      GRIN (NMDAR) [HSA:2902 2903 2904 2905 2906] [KO:K05208 K05209 K05210 K05211 K05212]
  PATHWAY   hsa04080(2902+2903+2904+2905+2906)  Neuroactive ligand-receptor interaction
            hsa04724(2902+2903+2904+2905+2906)  Glutamatergic synapse
METABOLISM  Enzyme: CYP2B6 [HSA:1555], CYP3A4 [HSA:1576]; CYP2C9 [HSA:1559], CYP2C19 [HSA:1557], UGT [KO:K00699]
INTERACTION  
STR_MAP     map07235  N-Methyl-D-aspartic acid (NMDA) receptor antagonists
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             N NERVOUS SYSTEM
              N01 ANESTHETICS
               N01A ANESTHETICS, GENERAL
                N01AX Other general anesthetics
                 N01AX14 Esketamine
                  D07283  Esketamine (USAN/INN)
              N06 PSYCHOANALEPTICS
               N06A ANTIDEPRESSANTS
                N06AX Other antidepressants
                 N06AX27 Esketamine
                  D07283  Esketamine (USAN/INN)
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG01498  NMDA receptor antagonist
               DG01829  Esketamine
                D07283  Esketamine
             Metabolizing enzyme substrate
              DG02919  CYP2B6 substrate
               DG01829  Esketamine
                D07283  Esketamine
              DG01642  CYP2C9 substrate
               DG01829  Esketamine
                D07283  Esketamine
              DG01639  CYP2C19 substrate
               DG01829  Esketamine
                D07283  Esketamine
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG01829  Esketamine
                 D07283  Esketamine
              DG02924  UGT substrate
               DG01829  Esketamine
                D07283  Esketamine
            Target-based classification of drugs [BR:br08310]
             Ion channels
              Ligand-gated ion channels
               Glutamate (ionotropic), NMDA
                GRIN (NMDAR)
                 D07283  Esketamine (USAN/INN)
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D07283
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG01498  NMDA receptor antagonist
               DG01829  Esketamine
             Metabolizing enzyme substrate
              DG02919  CYP2B6 substrate
               DG01829  Esketamine
              DG01642  CYP2C9 substrate
               DG01829  Esketamine
              DG01639  CYP2C19 substrate
               DG01829  Esketamine
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG01829  Esketamine
              DG02924  UGT substrate
               DG01829  Esketamine
DBLINKS     CAS: 33643-46-8
            PubChem: 51091620
            ChEBI: 60799
            PDB-CCD: JC9
            LigandBox: D07283
            NIKKAJI: J238.630E
ATOM        16
            1   C1z C    19.3775  -16.0455
            2   C8y C    18.1910  -16.7434
            3   C5x C    20.7733  -16.0455
            4   C1x C    18.6796  -14.8590
            5   N1b N    20.0754  -17.2319
            6   C8y C    16.9348  -16.0455
            7   C8x C    18.1910  -18.1392
            8   C1x C    21.4712  -14.7892
            9   O5x O    21.4712  -17.2319
            10  C1x C    19.3775  -13.6028
            11  C1a C    19.3775  -18.4882
            12  C8x C    15.7483  -16.7434
            13  X   Cl   16.9348  -14.6496
            14  C8x C    16.9348  -18.8371
            15  C1x C    20.7733  -13.6028
            16  C8x C    15.7483  -18.1392
BOND        17
            1     1   2 1
            2     1   3 1
            3     1   4 1
            4     1   5 1 #Down
            5     2   6 2
            6     2   7 1
            7     3   8 1
            8     3   9 2
            9     4  10 1
            10    5  11 1
            11    6  12 1
            12    6  13 1
            13    7  14 2
            14    8  15 1
            15   12  16 2
            16   10  15 1
            17   14  16 1
///
